Fecal microbial and metabolic signatures in children with very early onset inflammatory bowel disease
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Very early onset inflammatory bowel disease (VEO-IBD) in children shows distinct gut microbiome and metabolic changes. This study identifies specific bacterial and lipid alterations, offering insights for better VEO-IBD treatment strategies.
Area Of Science
- Gastroenterology
- Microbiology
- Metabolomics
Background
- Very early onset inflammatory bowel disease (VEO-IBD) affects children under six with severe, treatment-resistant disease.
- Limited research exists on the fecal microbiome and metabolome in VEO-IBD compared to adult and pediatric IBD.
- Understanding VEO-IBD's unique characteristics is crucial for developing effective therapies.
Purpose Of The Study
- To investigate the fecal microbiome and metabolome in children with VEO-IBD.
- To compare these profiles with age- and sex-matched healthy controls.
- To integrate multi-omics data to understand disease mechanisms.
Main Methods
- Multi-omics analysis including untargeted metabolomics and 16S rRNA sequencing.
- Comparison of fecal samples from VEO-IBD patients and healthy controls.
- Differential abundance analysis and multi-omics integration.
Main Results
- Depletion of short-chain N-acyl lipids and enrichment of dipeptides, tripeptides, and oxo bile acids in VEO-IBD.
- Reduced abundance of Bifidobacterium and Blautia; increased abundance of Lachnospira, Veillonella, and Bacteroides in VEO-IBD.
- Significant associations found between gut microbiome alterations and N-acyl lipid dysregulation.
Conclusions
- VEO-IBD exhibits unique fecal microbial and metabolic signatures.
- These findings provide novel insights into VEO-IBD pathogenesis.
- This research may lead to improved diagnostic and therapeutic strategies for VEO-IBD.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...